Nassir F. Marrouche, MD, FHRS

Associate Professor of Medicine
Executive Director, CARMA Center
Director, Cardiac Electrophysiology Laboratories
Director, Atrial Fibrillation Program
| Office: Assistant: Fax: Email: |
(801) 587-5888 (801) 581-2572 (801) 581-7735 nassir.marrouche@hsc.utah.edu |
Office Address:
University of Utah School of Medicine
Division of Cardiology
30 North 1900 East, Room 4A100
Salt Lake City, UT 84132
Education and Training:
Medical School: University of Heidelberg, Germany
Residency: 1997-1998 - Internal Medicine and Cardiology at the University of Heidelberg/Germany; 1998/2000 - Internal Medicine and Cardiology at the University of Wurzburg, Klinikum Coburg, Coburg/Germany
Clinical Fellowships: 3/00-9/00 Section of Cardiac Electrophysiology, Department of Cardiology, University of California, San Francisco; 9/00-2/03 Section of Pacing and Electrophysiology, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation
Clinical Specialties:
- Electrophysiology
Research Interests:
- Atrial Fibrillation: Pathophysiology and Novel Treatment Modalities
- Defining new imaging modalities for treatment of atrial and ventricular arrhythmias
Recent Publications:
- Badger TJ, Adjei-Poku YA, Marrouche NF. (2009). MRI in cardiac electrophysiology: the emerging role of delayed-enhancement MRI in atrial fibrillation ablation. Future Cardiol, 5(1), 63-70.
- Badger TJ, Oakes RS, Daccarett M, Burgon NS, Akoum N, Fish EN, Blauer JJ, Rao SN, Adjei-Poku Y, Kholmovski EG, Vijayakumar S, Di Bella EV, Macleod RS, Marrouche NF. (2009). Temporal left atrial lesion formation after ablation of atrial fibrillation. Heart Rhythm, 6(2), 161-8.
- Nolker G, Ritscher G, Gutleben KJ, Marschang H, Schmidt M, Rittger H, Mayer D, Marrouche N, Brachmann J, Sinha AM. (2009). Esophageal acid levels after pulmonary vein isolation for atrial fibrillation. Pacing Clin Electrophysiol, 32 Suppl 1, S228-30.
- Sinha AM, Schmidt M, Marschang H, Gutleben K, Ritscher G, Brachmann J, Marrouche NF. (2009). Role of left ventricular scar and Purkinje-like potentials during mapping and ablation of ventricular fibrillation in dilated cardiomyopathy. Pacing Clin Electrophysiol, 32(3), 286-90.
- Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN, Blauer JJ, Rao SN, DiBella EV, Segerson NM, Daccarett M, Windfelder J, McGann CJ, Parker D, MacLeod RS, Marrouche NF. (2009). Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation, 119(13), 1758-67.
- Schmidt M, Segerson NM, Marschang H, Akoum N, Rittger H, Clifford SM, Brachmann J, Daccarett M, Marrouche NF. (2009). Atrial fibrillation ablation in patients with therapeutic international normalized ratios. Pacing Clin Electrophysiol, 32(8), 995-9.
- Marrouche NF, Brachmann J. (2009). Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation (CASTLE-AF) - study design. Pacing Clin Electrophysiol, 32(8), 987-94.
- Badger TJ, Adjei-Poku YA, Burgon NS, Kalvaitis S, Shaaban A, Sommers DN, Blauer JJ, Fish EN, Akoum N, Haslem TS, Kholmovski EG, MacLeod RS, Adler DG, Marrouche NF. (2009). Initial experience of assessing esophageal tissue injury and recovery using delayed-enhancement MRI after atrial fibrillation ablation. Circ Arrhythm Electrophysiol, 2(6), 620-5.
- Segerson NM, Daccarett M, Badger TJ, Shabaan A, Akoum N, Fish EN, Rao S, Burgon NS, Adjei-Poku Y, Kholmovski E, Vijayakumar S, Dibella EV, Macleod RS, Marrouche NF. (2010). Magnetic Resonance Imaging-Confirmed Ablative Debulking of the Left Atrial Posterior Wall and Septum for Treatment of Persistent Atrial Fibrillation: Rationale and Initial Experience. J Cardiovasc Electrophysiol, 21(2), 126-32.
- Badger TJ, Daccarett M, Akoum NW, Adjei-Poku YA, Burgon NS, Haslam TS, Kalvaitis S, Kuppahally S, Vergara G, McMullen L, Anderson PA, Kholmovski E, Macleod RS, Marrouche NF. (2010). Evaluation of Left Atrial Lesions after Initial and Repeat Atrial Fibrillation Ablation: Lessons Learned from Delayed-Enhancement MRI in Repeat Ablation Procedures. Circ Arrhythm Electrophysiol, 3(3), 249-59.
- Kuppahally SS, Akoum N, Badger TJ, Burgon NS, Haslam T, Kholmovski E, Macleod R, McGann C, Marrouche NF. (2010). Echocardiographic left atrial reverse remodeling after catheter ablation of atrial fibrillation is predicted by preablation delayed enhancement of left atrium by magnetic resonance imaging. Am Heart J, 160(5), 877-84.
- Vergara GR, Marrouche NF. (2010). Tailored Management of Atrial Fibrillation Using a LGE-MRI Based Model: From the Clinic to the Electrophysiology Laboratory. J Cardiovasc Electrophysiol, 22(4), 481-7.
- Akoum N, Daccarett M, McGann C, Segerson N, Vergara G, Kuppahally S, Badger T, Burgon N, Haslam T, Kholmovski E, Macleod R, Marrouche N. (2011). Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: a DE-MRI guided approach. J Cardiovasc Electrophysiol, 22(1), 16-22LID - 10.1111/j.1540-8167.2010.01876.x [doi].
- Daccarett M, McGann CJ, Akoum NW, MacLeod RS, Marrouche NF. (2011). MRI of the left atrium: predicting clinical outcomes in patients with atrial fibrillation. Expert Rev Cardiovasc Ther, 9(1), 105-11.
- Kuppahally SS, Akoum N, Burgon NS, Badger TJ, Kholmovski EG, Vijayakumar S, Rao SN, Blauer J, Fish EN, Dibella EV, Macleod RS, McGann C, Litwin SE, Marrouche NF. (2010). Left Atrial Strain and Strain Rate in Patients with Paroxysmal and Persistent Atrial Fibrillation: Relationship to Left Atrial Structural Remodeling Detected by Delayed Enhancement-MRI. Circ Cardiovasc Imaging, 3(3), 231-9.
- Vergara GR, Lori McMullan L, Marrouche NF. (2011). Right atrial perforation at the end of an atrial fibrillation ablation procedure. doi: 10.1093/europace/eur006©. Europace, 13(6), 901-902.
